Testing for human papillomavirus (HPV) can be conducted in the privacy of one’s home, according to Nurx, a consumer health and telemedicine company that is offering home HPV screening tests to women.
To obtain a kit, patients must first answer a few medical history questions to determine if they are appropriate candidates for at-home testing; eligible patients will then receive the testing kit in the mail. Using the provided swab, the patient collects a vaginal sample and sends it back to the lab via a pre-paid envelope. Within 7 days, the medical team at Nurx will contact the patient to discuss the results.
“Nurx’s Home HPV Screening test provides women with vital information to help inform their healthcare decisions, but from the convenience of their own home,” said Nurx CEO and co-founder Hans Gangeskar. “We believe that everyone deserves to have easy and affordable access to this important information in order to potentially lower their risk for cervical cancer. The Home HPV Screening test is currently available in 20 states and the District of Columbia.
In addition to HPV screening, Nurx also provides prescriptions for contraceptives and pre-exposure prophylaxis (PrEP) medication for HIV prevention.
For more information visit Nurx.com.
This article originally appeared on MPR